1. Institute of Biomedical Chemistry, Moscow, Russia 2. Institute of Biomedical Chemistry, Moscow, Russia; Medico-biological faculty, Pirogov Russian National Research Medical University (RNRMU), Moscow, Russia
The majority of xenobiotics undergo a number of chemical reactions known as biotransformation in human body. The biological activity, toxicity, and other properties of the metabolites may significantly differ from those of the parent compound. Not only xenobiotic itself and its final metabolites produced in large quantities, but the intermediate and final metabolites that are formed in trace quantities, can cause undesirable effects. We have developed a freely available web resource MetaTox (http://www.way2drug.com/mg/) for integral assessment of xenobiotics toxicity taking into account their metabolism in the humans. The generation of the metabolite structures is based on the reaction fragments. The estimates of the probability of the reaction of a certain class and the probability of site of biotransformation are used at the generation of the xenobiotic metabolism pathways. The web resource MetaTox allows researchers to assess the metabolism of compounds in the humans and to obtain assessment of their acute, chronic toxicity, and adverse effects.
Rudik A.V., Dmitriev A.V., Lagunin A.A., Ivanov S.M., Filimonov D.A., Poroikov V.V. (2019) Xenobiotic toxicity prediction combined with xenobiotic metabolism prediction in the human body. Biomeditsinskaya Khimiya, 65(2), 114-122.
Rudik A.V. et al. Xenobiotic toxicity prediction combined with xenobiotic metabolism prediction in the human body // Biomeditsinskaya Khimiya. - 2019. - V. 65. -N 2. - P. 114-122.
Rudik A.V. et al., "Xenobiotic toxicity prediction combined with xenobiotic metabolism prediction in the human body." Biomeditsinskaya Khimiya 65.2 (2019): 114-122.
Rudik, A. V., Dmitriev, A. V., Lagunin, A. A., Ivanov, S. M., Filimonov, D. A., Poroikov, V. V. (2019). Xenobiotic toxicity prediction combined with xenobiotic metabolism prediction in the human body. Biomeditsinskaya Khimiya, 65(2), 114-122.
Testa B., Jenner B. (1976) in Drug metabolism: chemical and biochemical aspects (Ed. H. Oelschläger). Marcel Dekker Inc., New York, 1976. Scholar google search
Benedetti M.S., Whomsley R., Poggesi I., Cawello W., Mathy F.X., Delporte M.L., Papeleu P., Watelet J.B. (2009) Drug Metab. Rev., 41(3), 344-390. CrossRef Scholar google search
Liu W., Shi J., Zhu L., Dong L., Luo F., Zhao M., Wang Y., Hu M., Lu L., Liu Z. (2015) Drug Des Devel Ther., 9, 5771-5783. CrossRef Scholar google search
van Eij S., Zh, Z., Cupit, J., Gierula M., Götz C., Fritsche E., Edwards R.J. (2012) PLoS One, 7(7), e41721. CrossRef Scholar google search
Safety Testing of Drug Metabolites Guidance for Industry (2016) FDA. URL: https://www.fda.gov/downloads/Drugs/.../Guidances/ucm079266.pdf. Scholar google search
Kirchmair J., Williamson M.J., Tyzack J.D., Tan L., Bond P.J., Bender A., Glen R.C. (2012) J. Chem. Inf. Model., 52(3), 617-648. CrossRef Scholar google search
Kirchmair J., Göller A.H., Lang D., Kunze J., Testa B., Wilson I.D., Glen R.C., Schneider G. (2015) Nat. Rev. Drug Discov., 14(6), 387-404. CrossRef Scholar google search
Wang B., Yang L.-P., Zhang X.-Z., Huang S.-Q., Bartlam M., Zhou S.-F. (2009) Drug Metab. Rev., 41(4), 573-643. CrossRef Scholar google search
Kalgutkar A.S., Dalvi D., Obach R.S., Smith D.A. (2012) Reactive Drug Metabolites (Mannhold R., Kubinyi H., Folkers G., eds.), Willey-VCH. Scholar google search
